Document Details

Royal Free Hospital and University College London

Dr Indran Balakrishnan

Tags

antimicrobial drugs antibiotics medical microbiology pharmacology

Summary

This presentation discusses antimicrobial drugs, their mechanisms of action, safety concerns, and the increasing issue of antibiotic resistance. It details the different types of antibiotics and their sources, along with the various considerations for their appropriate use.

Full Transcript

Antimicrobial drugs DR INDRAN BALAKRISHNAN CONSULTANT/HON. ASSOC. PROFESSOR IN MEDICAL MICROBIOLOGY ROYAL FREE HOSPITAL AND UNIVERSITY COLLEGE LONDON Content  Concept of selective toxicity  Main groups of antibiotics and examples  Pharmacokinetic and pharmacodynamic concepts rele...

Antimicrobial drugs DR INDRAN BALAKRISHNAN CONSULTANT/HON. ASSOC. PROFESSOR IN MEDICAL MICROBIOLOGY ROYAL FREE HOSPITAL AND UNIVERSITY COLLEGE LONDON Content  Concept of selective toxicity  Main groups of antibiotics and examples  Pharmacokinetic and pharmacodynamic concepts relevant to antibiotic use  Safety concerns around antibiotics  Antibiotic resistance  Rational use of antibiotics ILO  To gain a broad overview of the mechanisms of action of antibiotics  To gain an overview of the various considerations involved in antibiotic use  To appreciate the significance of the spectre of antibiotic resistance Antimicrobial Drugs Antibiotic: Substance produced by a microorganism that in small amounts inhibits the growth of another microbe. Antibiotic producing microbes include:  Gram-Positive Rods:  Bacillus subtilis: Bacitracin  Bacillus polymyxa: Polymyxin  Fungi:  Penicillium notatum: Penicillin  Cephalosporium spp.: Cephalothin  Actinomycetes:  Streptomyces venezuelae: Chloramphenicol  Streptomyces griseus: Streptomycin  Streptomyces nodosus: Amphotericin B  Micromonospora purpurea: Gentamicin Antimicrobial Mechanisms of Action Selective Toxicity  Inhibition of Cell Wall Synthesis: Interfere with peptidoglycan synthesis.  Result in cell lysis.  Low toxicity. E.g. B-lactams (Penicillin) Glycopeptides (Vancomycin) Β-Lactams  3 groups  Penicillins  Cephalosporins  Carbapenems  Inhibit enzymes involved in cell wall assembly  No activity against atypical organisms  Mycoplasma  Legionella  Chlamydia Glycopeptides Antimicrobial Mechanisms of Action  Inhibition of Protein Synthesis: Interfere with procaryotic (70S) ribosomes, also found in mitochondria.  Most have broad spectrum of activity E.g. Tetracyclines Macrolides (erythromycin) Aminoglycosides (gentamicin) Macrolides - Action & Resistance Quiz 1  The site of action of B-lactam antibiotics is:  A) Cell membrane  B) Cell wall  C) DNA  D) Mitochondria  E) Ribosome Quiz 1  Cell wall – transglycosylases and transpeptidases involved in peptidoglycan biosynthesis Antimicrobial Mechanisms of Action Selective Toxicity  Injury to the Plasma Membrane: Cause changes in membrane permeability.  Result in loss of metabolites and/or cell lysis.  Many polypeptide antibiotics. E.g. Polymyxin B (antibacterial) or fluconazole (antifungal).  Inhibition of Nucleic Acid (DNA/RNA) Synthesis: Interfere with DNA replication and transcription. E.g. Quinolones (Ciprofloxacin) Quinolones - Mode of Action Antimicrobial Mechanisms of Action  Selective Toxicity  Inhibition of Synthesis of Essential Metabolites: Involve competitive inhibition of key enzymes.  Closely resemble substrate of enzyme. E.g. Trimethoprim inhibits the synthesis of folic acid. Antifolates – Mode of Action Influences on drug efficacy  Distribution (pharmacodynamics) in body (membrane permeability lipid soluble/active transport)  Concentrations in tissues, bone, CSF, bile etc  Metabolism (pharmacokinetics)- can the antibiotic be broken down and rendered ineffective?  Excretion (liver, kidneys)- Does renal/liver impairment lead to toxicity?  Dosing Regimens Appropriate therapy  Administration either external (topical) or systemic (blood stream)  Systemic drugs can be administered intravenously, intramuscularly or orally  Frequency of doses can vary Safety Concerns with the Use of Antimicrobials: Toxicity Kidney and ear damage (aminoglycosides) Liver damage Pseudomembranous colitis  Interactions with other medications May neutralize effectiveness of contraceptive pills  Hypersensitivity reactions Anaphylactic reactions to penicillin  Foetal damage/risk to pregnant women Tetracycline causes discoloration of teeth in children and may cause liver damage in pregnant women Fluoroquinolones may cause cartilage damage.  Antibiotic Resistance Quiz 3 The main side effect of gentamicin is: a) Bone marrow suppression b) Nephrotoxicity c) Neurotoxicity d) Rash e) Tooth discoloration Quiz 3  Nephrotoxicity  Ototoxicity  Serum levels are monitored Evolution of Resistance Genetics  Random genetic event  Acquisition of DNA  Plasmids  Transposons  Naked DNA  Alteration of DNA  Mutation  Loss of DNA  Deletion Bacteria and Genes 2 2 IB  Antibiotics kill bacteria by inactivating or damaging bacterial proteins  All bacterial proteins are encoded by bacterial genes  These genes are being changed and exchanged continually  So the proteins they encode are also being changed and exchanged Resistance Mechanisms Quiz 2  The action of B-lactamases is to:  A) Break down B-lactam antibiotics  B) Inhibit fungal replication  C) Inhibit DNA supercoiling  D) Inhibit protein synthesis  E) Reduce the emergence of resistance Quiz 2  B-lactamases hydrolyse B-lactam antibiotics, rendering them inactive. Fitness Cost of Resistance 2  These resistance mechanisms impose a biological cost  Resistant bacteria grow more slowly than sensitive bacteria 6 IB ……….unless an effective antibiotic is present  The effective antibiotic exerts a selection pressure on the bacterial population  Susceptible bacteria will die  Resistant bacteria will survive and multiply  A resistant population will replace the susceptible one  The antibiotic transforms the biological disadvantage of resistance into an overwhelming selective advantage Reducing Resistance 2 7 -Reduce Antibiotic Exposure IB  Does the patient need antibiotics?  Is there an infection?  Many non-infective illnesses can mimic infection  Acute asthma can look like pneumonia  Epilepsy can look like meningitis  Is the infection bacterial  Viral infections usually do not need treatment  Gastroenteritis  Pneumonia  Meningitis Reducing Resistance 2 8 -Keep The Antibiotic Spectrum Narrow IB  Some antibiotics are active against many different bacteria (broad spectrum)  Meropenem  Cefotaxime  Ceftriaxone  Some antibiotics are active against only a few bacteria (narrow spectrum)  Flucloxacillin  Trimethoprim  Nitrofurantoin  Metronidazole  In order for the antibiotic to exert selection pressure, it must be active against the organism  The narrower the spectrum, the less the selection pressure for resistance Reducing Resistance 2 9 -Start Smart Then Focus IB  Sometimes, when you have a sick patient, and you are not sure what is wrong with them, you have to start broad spectrum antibiotics  The important thing is to send off all the lab tests before you start  Review in 48 hours  Clinical state  White cell count  Temperature  Any cultures  And then ask these questions:  Does the patient need antibiotics?  Is this the most appropriate antibiotic? Reducing Resistance 3 0 -Keep The Antibiotic Duration Short IB  Selection pressure is only exerted in the presence of the antibiotic  Every dose exerts additional pressure  Stop the antibiotic and the pressure disappears  If an antibiotic has been started, and tests subsequently show that there is no bacterial infection  STOP the antibiotic  There is no need to “complete the course”  Most infections resolve within 5D  Most antibiotics should be stopped within 5D Summary  Many derived from biological sources  Different sites of action – “target site”  Selective toxicity  PD/PK determine dosage and route of administration QR code  Toxicity for student feedback  Drug resistance of increasing concern

Use Quizgecko on...
Browser
Browser